financetom
Business
financetom
/
Business
/
Market Chatter: TD Bank CEO Asks Shareholders For Patience As U.S. Regulatory Probe Stretches Into Second Year
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: TD Bank CEO Asks Shareholders For Patience As U.S. Regulatory Probe Stretches Into Second Year
Apr 18, 2024 2:04 PM

04:31 PM EDT, 04/18/2024 (MT Newswires) -- Toronto-Dominion Bank ( MLWIQXX ) chief executive officer Bharat Masrani pleaded with shareholders for patience on the probe by U.S. regulators into the lender's anti-money laundering practices as the investigation stretches into its second year, The Globe and Mail newspaper is reporting Thursday.

It noted Masrani fielded questions at the company's annual meeting from frustrated shareholders, who asked about the status of a lengthy probe by U.S. regulators that derailed the bank's takeover of Tennessee-based First Horizon Corp. last spring.

Masrani said he still cannot provide further details on the investigation as the bank is working on addressing the concerns from U.S. regulatory and law-enforcement agencies.

Last year, the report noted, TD said that it expects to face fines or other penalties stemming from probes by regulators and law-enforcement agencies, including the U.S. Department of Justice, related to its anti-money laundering practices. Some analysts have estimated that the fine could range from US$500-million to US$1-billion.

The probe, the report also noted, drove the derailment of TD's acquisition of Tennessee-based First Horizon Corp., a takeover that would have significantly accelerated TD's growth ambitions in the U.S.

The bank's efforts to remediate its anti-money laundering processes are weighing heavily on its balance sheet, the report said, noting that last year TD said it expects to post an adjusted net loss of $200-million to $250-million per quarter this year in its internal corporate segment, driven by investments in its risk and control infrastructure.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
UK competition regulator clears Boeing and Spirit AeroSystems merger
UK competition regulator clears Boeing and Spirit AeroSystems merger
Aug 8, 2025
Aug 8 (Reuters) - Britain's competition regulator on Friday said it had cleared Boeing's ( BA ) planned acquisition of Spirit AeroSystems ( SPR ) after deciding to not refer the deal to an in-depth investigation. ...
Progyny's Q2 Adjusted Earnings, Revenue Increase; 2025 Outlook Raised
Progyny's Q2 Adjusted Earnings, Revenue Increase; 2025 Outlook Raised
Aug 8, 2025
05:04 AM EDT, 08/08/2025 (MT Newswires) -- Progyny ( PGNY ) reported Q2 adjusted earnings Thursday of $0.48 per diluted share, up from $0.43 a year earlier. Analysts polled by FactSet expected $0.43. Revenue for the quarter ended June 30 was $332.9 million, compared with $304.1 million a year earlier. Analysts surveyed by FactSet expected $320.1 million. The company said...
Arrowhead Pharmaceuticals Fiscal Q3 Loss Narrows, Reports Revenue
Arrowhead Pharmaceuticals Fiscal Q3 Loss Narrows, Reports Revenue
Aug 8, 2025
05:05 AM EDT, 08/08/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) reported late Thursday a fiscal Q3 loss of $1.26 per diluted share, narrower than a loss of $1.38 a year earlier. Analysts polled by FactSet expected a $0.95 loss. Revenue for the quarter ended June 30 was $27.8 million. The company reported no revenue a year earlier. Analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved